IXC 1.43% 7.1¢ invex therapeutics ltd

Ann: Global Phase 3 Trial of Presendin to Launch in Q4 2021, page-3

  1. 190 Posts.
    lightbulb Created with Sketch. 22
    Pragmatic approach. Not the Big Bang we wanted, but I like that management have taken action. Let’s get this ball rolling.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
7.1¢
Change
0.001(1.43%)
Mkt cap ! $5.336M
Open High Low Value Volume
7.2¢ 7.2¢ 7.0¢ $22.09K 312.8K

Buyers (Bids)

No. Vol. Price($)
1 10000 5.1¢
 

Sellers (Offers)

Price($) Vol. No.
6.9¢ 23 1
View Market Depth
Last trade - 15.16pm 19/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.